CBS 2019
CBSMD教育中心
中 文

科学研究

Abstract

Recommended Article

The Year in Cardiovascular Medicine 2020: Valvular Heart Disease: Discussing the Year in Cardiovascular Medicine for 2020 in the field of valvular heart disease is Professor Helmut Baumgartner and Dr Javier Bermejo. Mark Nicholls reports Association of Circulating Monocyte Chemoattractant Protein-1 Levels With Cardiovascular Mortality: A Meta-analysis of Population-Based Studies Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights From EMPEROR-Reduced The conductive function of biopolymer corrects myocardial scar conduction blockage and resynchronizes contraction to prevent heart failure Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation: The RE-DUAL PCI Trial Subanalysis Coronary plaque redistribution after stent implantation is determined by lipid composition: A NIRS-IVUS analysis Outcomes 2 Years After Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk

Original ResearchCirculation. 2018;139:489–501

JOURNAL:Circulation. Article Link

Phenotypic Refinement of Heart Failure in a National Biobank Facilitates Genetic Discovery

Aragam KG, Chaffin M, GRADE Investigators. Keywords: nonischemic cardiomyopathy; genetic discovery, heart failure; CAD; atrial fibrillation

FULL TEXT PDF